After decades without meaningful advances in gonorrhea treatment, the approval of new oral antibiotics marks a turning point in the fight against the infection. For the first time in decades, oral ...

DENVER -- The four-component meningococcal serogroup B vaccine (4CMenB; Bexsero) did not reduce gonorrhea incidence in high-risk men who have sex with men, according to a randomized trial. The ...

A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The pill matched the success of current treatments while avoiding injections and ...

The pathogen that causes the sexually transmitted disease gonorrhea is notorious for its ability to develop drug resistance. But now there are two more treatment options. In December, the U.S. Food ...

What Is Nuzolvence, and Why Does It Matter? Nuzolvence (zoliflodacin) is a new oral antibiotic approved by the FDA to treat uncomplicated gonorrhea of the urinary and genital tract. It is meant for ...

The FDA on Friday announced approval of zoliflodacin (Nuzolvence) as an oral treatment for gonorrhea, a day after approving oral gepotidacin (Blujepa) for the same indication. Zoliflodacin is the ...

The sexually transmitted disease has become increasingly resistant to existing antibiotics. By Andrew Jacobs The Food and Drug Administration has approved two new antibiotics for the treatment of ...

Dec 12 (Reuters) - The U.S. health regulator on Friday approved Innoviva's (INVA.O), opens new tab oral antibiotic to treat gonorrhea, a common sexually transmitted infection, offering patients an ...

Gepotidacin was noninferior to ceftriaxone plus azithromycin, achieving microbiological success in 92.6% of patients vs 91.2% in the comparator arm. The Food and Drug Administration (FDA) has approved ...

After a three-decade drought of new antibiotics to treat gonorrhea, the FDA has signed off on two first-in-class oral treatments for the sexually transmitted infection (STI), which affects more than ...

Innoviva received approval from the Food and Drug Administration for Nuzolvence, a treatment of gonorrhea. Nuzolvence has been approved as a single-dose oral medication to treat uncomplicated ...

Blujepa (gepotidacin) is an oral antibiotic for treating two common infections: uncomplicated urinary tract infections (UTIs) in females and uncomplicated urogenital gonorrhea. Its recent FDA approval ...